Amedeo Smart

Free Medical Literature Service


 

Amedeo

Schizophrenia

  Free Subscription

Articles published in
Psychiatry Res
    December 2024
  1. WYSOKINSKI A, Dreczka J
    Clozapine Toxicity Predictor: Deep neural network model predicting clozapine toxicity and its therapeutic dose range.
    Psychiatry Res. 2024;342:116256.
    >> Share

  2. SOLDEVILA-MATIAS P, Sanchez-Orti JV, Correa-Ghisays P, Balanza-Martinez V, et al
    Exercise as a promoter of neurocognitive improvement in people with psychiatric disorders and comorbid obesity: A randomized controlled trial.
    Psychiatry Res. 2024;342:116226.
    >> Share

  3. FLORENTIN S, Neumark Y, Roe D, Rosca P, et al
    The relationship between community-based psychiatric rehabilitation pathways and re-hospitalization trajectories: A three-decade follow-up.
    Psychiatry Res. 2024;342:116216.
    >> Share

  4. PISANU C, Congiu D, Meloni A, Paribello P, et al
    Sex differences in shared genetic determinants between severe mental disorders and metabolic traits.
    Psychiatry Res. 2024;342:116195.
    >> Share

    November 2024
  5. KUMAR M, Choudhary H, Chawla N
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study: Letter to the editor.
    Psychiatry Res. 2024;343:116299.
    >> Share

  6. GONCALVES CC, Waters Z, Quirk SE, Haddad PM, et al
    Barriers and facilitators to mental health care access and engagement for LGBTQA+ people with psychosis: A scoping review.
    Psychiatry Res. 2024;343:116281.
    >> Share

  7. REANGSING C, Wongsuraprakit S, Punsuwun S, Oerther S, et al
    Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2024;342:116272.
    >> Share

  8. LAMARCA M, Espinosa V, Acuna V, Vila-Badia R, et al
    Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions.
    Psychiatry Res. 2024;342:116262.
    >> Share

  9. BERE M, Rossell SL, Toh WL
    Cognition in relation to non-auditory or multisensory hallucinations in schizophrenia-spectrum disorders: A scoping review.
    Psychiatry Res. 2024;342:116268.
    >> Share

  10. ABRAHAM T, Gill H, Wood L
    Psychosocial interventions offered across inpatient and crisis settings to the social networks of service users with psychosis: A systematic review.
    Psychiatry Res. 2024;343:116267.
    >> Share

  11. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
    Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study.
    Psychiatry Res. 2024;342:116261.
    >> Share

  12. PUGH SL, Chandler C, Cohen AS, Diaz-Asper C, et al
    Assessing dimensions of thought disorder with large language models: The tradeoff of accuracy and consistency.
    Psychiatry Res. 2024;341:116119.
    >> Share

    October 2024
  13. CALZAVARA PINTON I, Nibbio G, Bertoni L, Cicale A, et al
    The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study.
    Psychiatry Res. 2024;342:116240.
    >> Share

  14. DEMIRLEK C, Verim B, Zorlu N, Demir M, et al
    Functional brain networks in clinical high-risk for bipolar disorder and psychosis.
    Psychiatry Res. 2024;342:116251.
    >> Share

  15. KISIANG'ANI IB, Aden M, Mwangi HR, Akena D, et al
    Exploring psychotic symptoms among substance-naive individuals and recent abstainers without a psychosis diagnosis: A cross-country study across Kenya, Uganda, Ethiopia, and South Africa.
    Psychiatry Res. 2024;342:116253.
    >> Share

  16. THIBAUDEAU E, Bowie CR, Montreuil T, Baer L, et al
    Acceptability, engagement, and efficacy of cognitive remediation for cognitive outcomes in young adults with first-episode psychosis and social anxiety: A randomized-controlled trial.
    Psychiatry Res. 2024;342:116243.
    >> Share

  17. GONZALES L, Saperstein AM, Qian M, Gorecki A, et al
    Psychiatric and functional correlates of stigma associated with cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;342:116233.
    >> Share

  18. CIOFFI L, Wein PY, Miller SA, Fagan S, et al
    Clinical, neurocognitive, neurobiological and functional correlates of sleep difficulties in individuals at-risk for psychosis and mania: A scoping review.
    Psychiatry Res. 2024;342:116235.
    >> Share

  19. DUDLEY R, White S, Miskin R, Oakes L, et al
    Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis.
    Psychiatry Res. 2024;342:116229.
    >> Share

  20. TORREY EF, Simmons W, Dailey L
    Schizophrenia, clinical and basic research at NIMH: A 75 Year retrospective.
    Psychiatry Res. 2024;342:116225.
    >> Share

  21. SARNYAI Z, Ben-Shachar D
    Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework.
    Psychiatry Res. 2024;342:116220.
    >> Share

  22. BERA S, Yang AB, Chung D, Arnesen R, et al
    Duffy-null associated neutrophil count and antipsychotic use.
    Psychiatry Res. 2024;340:116146.
    >> Share

    September 2024
  23. ARMARIO A, Nadal R, Fuentes S, Visa J, et al
    Prenatal immune activation in rats and adult exposure to inescapable shocks reveal sex-dependent effects on fear conditioning that might be relevant for schizophrenia.
    Psychiatry Res. 2024;342:116219.
    >> Share

  24. GIAMPETRUZZI E, Walker EF, Addington J, Bearden CE, et al
    Impact of adverse childhood experiences on risk for internalizing psychiatric disorders in youth at clinical high-risk for psychosis.
    Psychiatry Res. 2024;342:116214.
    >> Share

  25. TEYMOURI K, Ebrahimi M, Chen CC, Sriretnakumar V, et al
    Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency.
    Psychiatry Res. 2024;342:116202.
    >> Share

  26. SUKNO FM, Kelly BD, Lane A, Katina S, et al
    Loss of normal facial asymmetry in schizophrenia and bipolar disorder: Implications for development of brain asymmetry in psychotic illness.
    Psychiatry Res. 2024;342:116213.
    >> Share

  27. CIUFALO J, Zaccone S, Fatiga G, Caputo GB, et al
    Creative puppet therapy reduces hallucinations in patients diagnosed with schizophrenia: Preliminary findings.
    Psychiatry Res. 2024;342:116211.
    >> Share

  28. GLINERT A, Zlidennyy V, Turjeman S, Sharon E, et al
    What's GABA got to do with it? A potential link between the microbiome, schizophrenia, and the endo-cannabinoid system.
    Psychiatry Res. 2024;342:116196.
    >> Share

  29. DOMINGUEZ T, Puebla DP, Fresan A, Sheinbaum T, et al
    Why do some Mexicans with psychosis risk symptoms seek mental health care and others do not?
    Psychiatry Res. 2024;342:116199.
    >> Share

  30. CASANOVAS F, Dinamarca F, Posso M, Mane A, et al
    Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis.
    Psychiatry Res. 2024;342:116206.
    >> Share

  31. MEHTA UM, Roy N, Bahuguna A, Kotambail A, et al
    Incremental predictive value of genetic risk and functional brain connectivity in determining antipsychotic response in schizophrenia.
    Psychiatry Res. 2024;342:116201.
    >> Share

  32. TANG JMY, Chiu KKY, Yang C, Cheung DSK, et al
    Social cognition interventions for patients with first-episode psychosis: A scoping review.
    Psychiatry Res. 2024;342:116191.
    >> Share

  33. KRISTENSEN TD, Mager FM, Ambrosen KS, Barber AD, et al
    Cognitive profiles across the psychosis continuum.
    Psychiatry Res. 2024;342:116168.
    >> Share

  34. D'ANDREA G, Ouellet-Plamondon C, Villeneuve M, Shah JL, et al
    Joint-trajectories of clinical severity, social functioning and cannabis use in first-episode psychosis: A 5-year longitudinal study in 2 urban early intervention services.
    Psychiatry Res. 2024;342:116184.
    >> Share

  35. VALT C, Lopez-Caballero F, Tavella A, Altamura M, et al
    Abnormal inter-hemispheric effective connectivity from left to right auditory regions during Mismatch Negativity (MMN) tasks in psychosis.
    Psychiatry Res. 2024;342:116189.
    >> Share

  36. BORNHEIMER LA, Bagge CL, Overholser J, Brdar NM, et al
    Demographic and clinical characteristics of individuals with psychosis symptoms who died by suicide: Findings of a psychological autopsy study.
    Psychiatry Res. 2024;342:116185.
    >> Share

  37. HSIEH KP, Liao WL, Ho PS, Lin JW, et al
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study.
    Psychiatry Res. 2024;342:116171.
    >> Share

  38. DE HAAS HJ, Cohen D, de Koning MB, van Weringh G, et al
    Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER).
    Psychiatry Res. 2024;339:116070.
    >> Share

  39. PICCHIONI M, Ruiz R, de Girolamo G, Iozzino L, et al
    The predictive validity and temporal characteristics of the HCR-20v3 for inpatient violence in forensic inpatient settings. An international study.
    Psychiatry Res. 2024;339:116079.
    >> Share

  40. ZACHOS KA, Choi J, Godin O, Chernega T, et al
    Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder.
    Psychiatry Res. 2024;339:116063.
    >> Share

  41. LUYKX JJ, Tanskanen A, Lahteenvuo M, Manu P, et al
    Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking.
    Psychiatry Res. 2024;339:116012.
    >> Share

    August 2024
  42. MORKVED N, Johnsen E, Kroken RA, Joa I, et al
    Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study.
    Psychiatry Res. 2024;341:116169.
    >> Share

  43. SNELLEKSZ M, Dean B
    Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors.
    Psychiatry Res. 2024;341:116156.
    >> Share

  44. MORO L, Sicotte R, Joober R, Malla A, et al
    Trajectories of suicidality during a 2-year early-intervention program for first-episode psychosis: A longitudinal study.
    Psychiatry Res. 2024;340:116148.
    >> Share

  45. COHEN S, Goldsmith DR, Ning CS, Addington J, et al
    Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2024;341:116147.
    >> Share

  46. TSUI HKH, Luk SL, Hsiao J, Chan SKW, et al
    Facial emotion perception in individuals with clinical high risk for psychosis compared with healthy controls, first-episode psychosis, and in predicting psychosis transition: A systematic review and meta-analysis.
    Psychiatry Res. 2024;340:116143.
    >> Share

  47. GUZMAN A, Klein H, Keefe RS, Horan WP, et al
    Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;340:116121.
    >> Share

  48. GIANNOUCHOS TV, Ohsfeldt RL, Kum HC
    Trends and disparities in emergency department visits for schizophrenia spectrum disorders in Texas from 2019 to 2022.
    Psychiatry Res. 2024;340:116139.
    >> Share

  49. MENDEZ-VICTORIANO G, Zhu Y, Middleton F, Massa PT, et al
    Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder.
    Psychiatry Res. 2024;340:116141.
    >> Share

  50. VITA G, Pollini D, Canozzi A, Papola D, et al
    Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis.
    Psychiatry Res. 2024;340:116124.
    >> Share

  51. VITA A, Nibbio G, Barlati S
    Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;340:116126.
    >> Share

    July 2024
  52. MAZZAROTTO F, Monteleone P, Minelli A, Mattevi S, et al
    Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis.
    Psychiatry Res. 2024;340:116107.
    >> Share

  53. GREVE AN, Hemager N, Mortensen EL, Gantriis DL, et al
    Comparing cognition in parents with schizophrenia or bipolar disorder and their 7-year-old offspring.
    Psychiatry Res. 2024;340:116112.
    >> Share

  54. LUCARINI V, Grice M, Wehrle S, Cangemi F, et al
    Language in interaction: turn-taking patterns in conversations involving individuals with schizophrenia.
    Psychiatry Res. 2024;339:116102.
    >> Share

  55. BLOSE BA, Silverstein SM, Stuart KV, Keane PA, et al
    Association between polygenic risk for schizophrenia and retinal morphology: A cross-sectional analysis of the United Kingdom Biobank.
    Psychiatry Res. 2024;339:116106.
    >> Share

  56. FEKIH-ROMDHANE F, Ghrissi F, Abassi B, Loch AA, et al
    Impulsivity as a predictor of clinical and psychological outcomes in a naturalistic prospective cohort of subjects at ultra-high risk (UHR) for psychosis from Tunisia.
    Psychiatry Res. 2024;340:116090.
    >> Share

  57. COFFMAN BA, Curtis M, Seebold D, Kocsis J, et al
    Long-latency auditory evoked response amplitudes at first episode of psychosis predict six-month recovery in positive symptom severity.
    Psychiatry Res. 2024;339:116094.
    >> Share

  58. LOURENCO PJDS, Bastos TCL, Pizarro AIN, Corredeira RMN, et al
    Feasibility and effectiveness of a 24-weeks outdoor exercise program on the physical and mental health of persons with schizophrenia.
    Psychiatry Res. 2024;339:116093.
    >> Share

  59. THELWELL ELR, Dunkerley L, Goodwin R, Giacco D, et al
    Effectiveness of online social networking interventions on social isolation and quality of life of people with psychosis: A systematic review.
    Psychiatry Res. 2024;339:116088.
    >> Share

  60. BIAN Y, Kawabata R, Enwright JF, Tsubomoto M, et al
    Expression of activity-regulated transcripts in pyramidal neurons across the cortical visuospatial working memory network in unaffected comparison individuals and individuals with schizophrenia.
    Psychiatry Res. 2024;339:116084.
    >> Share

  61. SCHUTZ A, Salahuddin NH, Priller J, Bighelli I, et al
    The role of control groups in non-pharmacological randomised controlled trials of treatment-resistant schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2024;339:116069.
    >> Share

  62. SIDDI S, Ochoa S, Laroi F, Lincoln TM, et al
    A cross-national investigation of psychosis-like experiences in five European countries included in the E-CLECTIC study: Psychometric challenges in studying their measurement.
    Psychiatry Res. 2024;339:116072.
    >> Share

  63. WANNAN CMJ, Eratne D, Santillo AF, Malpas C, et al
    Plasma neurofilament light protein is differentially associated with age in individuals with treatment-resistant schizophrenia and bipolar affective disorder compared to controls.
    Psychiatry Res. 2024;339:116073.
    >> Share

  64. WILTSCHKO M
    Is grammar affected in Schizophrenia?
    Psychiatry Res. 2024;339:116061.
    >> Share

  65. CHAN SKW, Pang TSW, Tsui HKH, Suen YN, et al
    Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia.
    Psychiatry Res. 2024;337:115985.
    >> Share

    June 2024
  66. MELISSA B, Sabrina G, Charles-Edouard G, Hind Z, et al
    Clinical characteristics associated with functioning trajectories following admission to a psychiatric institution: A prospective cohort study of individuals with psychosis.
    Psychiatry Res. 2024;339:116062.
    >> Share

  67. COLIJN MA
    Genetic testing in individuals experiencing psychosis: A practical guide for psychiatrists.
    Psychiatry Res. 2024;339:116052.
    >> Share

  68. ANDERSEN HG, DellaValle B, Bogehave H, Mogensen PB, et al
    Glycocalyx shedding patterns identifies antipsychotic-naive patients with first-episode psychosis.
    Psychiatry Res. 2024;339:116037.
    >> Share

  69. NADER G, Qureshi M, Chaudhary Z, Fischer CE, et al
    Effect of personality traits, psychological resilience and life adversities on lifetime violence trajectories: A novel classification model in schizophrenia.
    Psychiatry Res. 2024;339:116044.
    >> Share

  70. CHIEN WT, Chong YY, Bressington D, McMaster CW, et al
    A randomized controlled trial of an acceptance-based, insight-inducing medication adherence therapy (AIM-AT) for adults with early-stage psychosis.
    Psychiatry Res. 2024;339:116046.
    >> Share

  71. FERRARA M, Domenicano I, Marchi A, Zaffarami G, et al
    First episode psychoses in people over-35 years old: uncovering potential actionable targets for early intervention services.
    Psychiatry Res. 2024;339:116034.
    >> Share

  72. POUSA E, Brebion G, Lopez-Carrilero R, Ruiz AI, et al
    Predictors of clinical insight in first-episode psychosis: Different patterns in men and women.
    Psychiatry Res. 2024;339:116036.
    >> Share

  73. HOSTALET N, Gonzalez A, Salgado-Pineda P, Gonzalez-Colom R, et al
    Face-brain correlates as potential sex-specific biomarkers for schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;339:116027.
    >> Share

  74. BUCCI S, Berry N, Ainsworth J, Berry K, et al
    Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial.
    Psychiatry Res. 2024;339:116025.
    >> Share

  75. CHENG KY, Robinson N, Ploner A, Kuja-Halkola R, et al
    Impact of traumatic brain injury on risk for schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;339:115990.
    >> Share

  76. ROTELLA F, Falone A, Cassioli E, Mannucci E, et al
    The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies.
    Psychiatry Res. 2024;336:115895.
    >> Share

  77. MISHRA A, Maiti R, Ramasubbu MK, Srinivasan A, et al
    Evaluation of the pharmacodynamic interaction effect of augmentation agents with clozapine in patients with treatment-resistant schizophrenia: A simulation study of clinical data.
    Psychiatry Res. 2024;338:115989.
    >> Share

    May 2024
  78. WASTLER HM, Mengda Y, Pan X, Bornheimer LA, et al
    Trajectories of suicidal risk among individuals with first-episode psychosis: Relationship to recovery and symptoms.
    Psychiatry Res. 2024;338:115978.
    >> Share

  79. COLLINS M, Bartholomeusz C, Mei C, Kerr M, et al
    Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis.
    Psychiatry Res. 2024;337:115966.
    >> Share

  80. SANGIMINO M, Babbitt K, Lee HS, Park S, et al
    Bodily experiences of trauma and psychosis risk.
    Psychiatry Res. 2024;337:115961.
    >> Share

  81. OH H, Karcher NR, Li Verdugo J, Botello R, et al
    Ethno-racial disparities in psychosis-like experiences among students in higher education: Findings from the Healthy Minds Study 2020-2021.
    Psychiatry Res. 2024;337:115959.
    >> Share

  82. WU Y, Zhang CY, Zhang Y, Chen R, et al
    Genomic landscape and functional characterization of structural variations in schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;337:115929.
    >> Share

  83. BULDUK BK, Tortajada J, Valiente-Palleja A, Callado LF, et al
    High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;337:115928.
    >> Share

    April 2024
  84. GUO H, Zhong S, Lam ST, Wang N, et al
    Trends in violent offending among people with schizophrenia: A 10-year ecological study.
    Psychiatry Res. 2024;337:115935.
    >> Share

  85. BRADLEY ER, Portanova J, Woolley JD, Buck B, et al
    Quantifying abnormal emotion processing: A novel computational assessment method and application in schizophrenia.
    Psychiatry Res. 2024;336:115893.
    >> Share

  86. SMITH LC, Mateos AC, Due AS, Bergstrom J, et al
    Immersive virtual reality in the treatment of auditory hallucinations: A PRISMA scoping review.
    Psychiatry Res. 2024;334:115834.
    >> Share

    March 2024
  87. SPINAZZOLA E, Quattrone D, Quattrone A, Murray RM, et al
    The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use.
    Psychiatry Res. 2024;336:115869.
    >> Share

  88. HAMZEHPOUR L, Bohn T, Dutsch V, Jaspers L, et al
    From brain to body: exploring the connection between altered reward processing and physical fitness in schizophrenia.
    Psychiatry Res. 2024;335:115877.
    >> Share

  89. GALLEGO JA, McNamara RK, Blanco EA, Castaneda S, et al
    Evidence for cytokine dysregulation in schizophrenia spectrum disorders: A comparison of cerebrospinal fluid and blood samples.
    Psychiatry Res. 2024;335:115871.
    >> Share

  90. SEFIK E, Guest RM, Aberizk K, Espana R, et al
    Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
    Psychiatry Res. 2024;335:115867.
    >> Share

  91. SETHI S, Wakeham D, Ketter T, Hooshmand F, et al
    Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.
    Psychiatry Res. 2024;335:115866.
    >> Share

  92. YANG H, Zhu D, Liu Y, Xu Z, et al
    Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia.
    Psychiatry Res. 2024;335:115841.
    >> Share

  93. KISHI T, Citrome L, Sakuma K, Iwata N, et al
    A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
    Psychiatry Res. 2024;333:115761.
    >> Share

    February 2024
  94. GORORA ME, Dalkner N, Moore RC, Depp CA, et al
    A meta-cognitive Wisconsin Card Sorting Test in people with schizophrenia and bipolar disorder: Self-assessment of sorting performance.
    Psychiatry Res. 2024;334:115831.
    >> Share

  95. QIN K, Yu Y, Cai H, Li J, et al
    Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2024;334:115808.
    >> Share

  96. KIKUCHI Y, Komatsu H, Otsuka Y, Ito F, et al
    Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
    Psychiatry Res. 2024;334:115810.
    >> Share

  97. GOODING DC, Mohrbacher DA, Umucu E, Van Hulle CA, et al
    Ethnoracialized group differences in attitudes and knowledge about schizophrenia and willingness to engage in biomarker research: The UBIGR Study.
    Psychiatry Res. 2024;334:115776.
    >> Share

  98. HYATT AS, Mulvaney-Day N, Chow CM, Cook BL, et al
    Association between electronic nicotine product use and subsequent first episode psychosis.
    Psychiatry Res. 2024;334:115785.
    >> Share

  99. KWAK PP, Ibarra C, Hernandez A, Carrasco J, et al
    Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.
    Psychiatry Res. 2024;334:115788.
    >> Share

  100. QUIRINO AHA, da Rocha MEC, Andrade AGM, E Souza FGM, et al
    The demonstrated association: Cannabis use and onset of psychosis in the study by Medeiros et al., refuting the reverse notion.
    Psychiatry Res. 2024;334:115771.
    >> Share

    January 2024
  101. HE R, Palominos C, Zhang H, Alonso-Sanchez MF, et al
    Navigating the semantic space: Unraveling the structure of meaning in psychosis using different computational language models.
    Psychiatry Res. 2024;333:115752.
    >> Share

  102. KOS C, Bais L, Klaasen N, Opmeer E, et al
    Effects of right prefrontal theta-burst transcranial magnetic stimulation or transcranial direct current stimulation on apathy in patients with schizophrenia: A multicenter RCT.
    Psychiatry Res. 2024;333:115743.
    >> Share

  103. YI S, Wang Q, Wang W, Hong C, et al
    Efficacy of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms and cognitive functioning in schizophrenia: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2024;333:115728.
    >> Share

  104. TOUMAIAN M, Covanis P, Mantas A, Karantinos T, et al
    Multisensory integration deficits in Schizophrenia and Autism evidenced in behaviour but not event related potentials.
    Psychiatry Res. 2024;332:115727.
    >> Share

  105. PROHENS L, Rodriguez N, Segura AG, Martinez-Pinteno A, et al
    Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
    Psychiatry Res. 2024;332:115722.
    >> Share

  106. JEROME L, Matanov A, Bird V, Priebe S, et al
    Comparison of subjective quality of life domains in schizophrenia, mood, and anxiety disorders; an individual patient data meta-analysis.
    Psychiatry Res. 2024;332:115707.
    >> Share

  107. CHU RST, Chong RCH, Chang DHH, Shan Leung AL, et al
    The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study.
    Psychiatry Res. 2024;332:115713.
    >> Share

  108. SETIEN-SUERO E, Ayesa-Arriola R, Pena J, Ojeda N, et al
    Premorbid adjustment as predictor of long-term functionality: Findings from a 10-year follow-up study in the PAFIP-cohort.
    Psychiatry Res. 2024;331:115674.
    >> Share

  109. MASTELLARI T, Saint-Dizier C, Fovet T, Geoffroy PA, et al
    Exploring seasonality in catatonia diagnosis: Evidence from a large-scale population study.
    Psychiatry Res. 2024;331:115652.
    >> Share

    December 2023
  110. WANG Y, Zhang X
    The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in ECT for schizophrenia.
    Psychiatry Res. 2023;332:115708.
    >> Share

  111. VGONTZAS AN, Paschalidou A, Simos PG, Anastasaki M, et al
    Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder.
    Psychiatry Res. 2023;332:115676.
    >> Share

  112. TORREY EF
    Did the human genome project affect research on Schizophrenia?
    Psychiatry Res. 2023;333:115691.
    >> Share

  113. KIM WS, Shen J, Tsogt U, Odkhuu S, et al
    Altered thalamic volumes and functional connectivity in the recovered patients with psychosis.
    Psychiatry Res. 2023;331:115688.
    >> Share

  114. ZHOU D, Xie H, Chen L, Zhu Z, et al
    The cognitive improvement in patients with schizophrenia following low-intensity repetitive transcranial magnetic stimulation could last for 6 months: A randomized controlled trial.
    Psychiatry Res. 2023;332:115672.
    >> Share

  115. CHEN Y, Zhang L, Sun Y, Wang W, et al
    Prevalence of constipation in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;331:115659.
    >> Share

  116. DE MEDEIROS MW, Andrade JC, Haddad NM, Mendonca M, et al
    Cannabis use influences disorganized symptoms severity but not transition in a cohort of non-help-seeking individuals at-risk for psychosis from Sao Paulo, Brazil.
    Psychiatry Res. 2023;331:115665.
    >> Share

  117. DEAN B, Duce J, Li QX, Masters CL, et al
    Lower levels of soluble beta-amyloid precursor protein, but not beta-amyloid, in the frontal cortex in schizophrenia.
    Psychiatry Res. 2023;331:115656.
    >> Share

  118. FENG XZ, Li Z, Li ZY, Wang K, et al
    Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;332:115637.
    >> Share

  119. VINOGRADOV S
    Harnessing neuroplasticity.
    Psychiatry Res. 2023;330:115607.
    >> Share

  120. STAFFORD E, Jakob S, Gur RE, Corcoran CM, et al
    Securing direct stakeholder feedback to inform clinical research in serious mental illness: Results of a patient and family perspectives survey.
    Psychiatry Res. 2023;330:115574.
    >> Share

    November 2023
  121. GROENING JM, Denton E, Parvaiz R, Brunet DL, et al
    A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2023;331:115626.
    >> Share

  122. LAMANNA-RAMA N, Romero-Miguel D, Casquero-Veiga M, MacDowell KS, et al
    THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
    Psychiatry Res. 2023;331:115643.
    >> Share

  123. WEI Z, Wang Y, Hu L, Wang Y, et al
    Incidence, prevalence, and mortality of schizophrenia from 2016 to 2020 in Shandong, China.
    Psychiatry Res. 2023;331:115612.
    >> Share

  124. LEE J, Xue X, Au E, McIntyre WB, et al
    Central insulin dysregulation in antipsychotic-naive first-episode psychosis: In silico exploration of gene expression signatures.
    Psychiatry Res. 2023;331:115636.
    >> Share

  125. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    20-Year trajectories of six psychopathological dimensions in patients with first-episode psychosis: Could they be predicted?
    Psychiatry Res. 2023;331:115614.
    >> Share

  126. HU Q, Jiao X, Zhou J, Tang Y, et al
    Low-frequency repetitive transcranial magnetic stimulation over the right orbitofrontal cortex for patients with first-episode schizophrenia: A randomized, double-blind, sham-controlled trial.
    Psychiatry Res. 2023;330:115600.
    >> Share

  127. BOGE K, Hallford DJ, Pillny M
    Mindfulness, psychological flexibility and their relationship with psychopathology in persons with schizophrenia-spectrum-disorders and healthy controls - A multicenter cross-sectional study.
    Psychiatry Res. 2023;330:115591.
    >> Share

  128. DAZZAN P
    Disentangling psychosis: The challenges of informing precision medicine for what is not a single disorder.
    Psychiatry Res. 2023;330:115596.
    >> Share

  129. BERNARDIN F, Gauld C, Martin VP, Laprevote V, et al
    The 68 symptoms of the clinical high risk for psychosis: Low similarity among fourteen screening questionnaires.
    Psychiatry Res. 2023;330:115592.
    >> Share

  130. CORNBLATT BA, McFarlane WR, Carrion RE
    Authors' reply to comments on: Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;330:115594.
    >> Share

  131. KIRSHENBAUM AP, Sofis MJ, Slade M
    Response to recreational cannabis use over time in individuals at clinical high risk for psychosis: lack of associations with symptom, neurocognitive, functioning, and treatment patterns by Carrion et al., 2023.
    Psychiatry Res. 2023;330:115589.
    >> Share

  132. PARK S
    Schizophrenia in the mind, the brain and the body.
    Psychiatry Res. 2023;329:115547.
    >> Share

    October 2023
  133. BIRONG CHEN, Tan XW, Tor PC
    The impact of the number of previous illness episodes on early response to electroconvulsive therapy (ECT) in psychosis, mania, depression, psychotic depression, and catatonia: A naturalistic transdiagnostic analysis.
    Psychiatry Res. 2023;330:115580.
    >> Share

  134. KIM HK, Goncalves VF, Husain MI, Muller DJ, et al
    Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.
    Psychiatry Res. 2023;330:115563.
    >> Share

  135. LIN CH, Huang CJ, Lin TC, Chan HY, et al
    Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
    Psychiatry Res. 2023;330:115575.
    >> Share

  136. WANG P, Jiang Y, Hoptman MJ, Li Y, et al
    Structural-functional connectivity deficits of callosal-white matter-cortical circuits in schizophrenia.
    Psychiatry Res. 2023;330:115559.
    >> Share

  137. VAN DER TUIN S, Booij SH, Muller MK, van den Berg D, et al
    The added value of daily diary data in 1- and 3-year prediction of psychopathology and psychotic experiences in individuals at risk for psychosis.
    Psychiatry Res. 2023;329:115546.
    >> Share

  138. HASSAN L, Eisner E, Berry K, Emsley R, et al
    User engagement in a randomised controlled trial for a digital health intervention for early psychosis (Actissist 2.0 trial).
    Psychiatry Res. 2023;329:115536.
    >> Share

  139. SCHLIEF M, Rich N, Rains LS, Baldwin H, et al
    Ethnic differences in receipt of psychological interventions in Early Intervention in Psychosis services in England - a cross-sectional study.
    Psychiatry Res. 2023;330:115529.
    >> Share

  140. ZHANG T, Xu L, Wei Y, Tang X, et al
    Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis.
    Psychiatry Res. 2023;329:115522.
    >> Share

    September 2023
  141. SAMPEDRO A, Pena J, Sanchez P, Ibarretxe-Bilbao N, et al
    Moderators of functional improvement after integrative cognitive remediation in schizophrenia: Toward a personalized treatment approach.
    Psychiatry Res. 2023;329:115495.
    >> Share

  142. HUI CLM, Wong CCL, Chan EWT, Suen YN, et al
    COVID-19 exposure and psychosis: A comparison of clinical, functional, and cognitive profiles in remitted patients with psychosis.
    Psychiatry Res. 2023;328:115487.
    >> Share

  143. CAMPRODON-BOADAS P, De la Serna E, Plana MT, Flamarique I, et al
    Delusional beliefs in adolescents with anorexia nervosa, obsessive-compulsive disorder, or first-episode psychosis: A comparative study.
    Psychiatry Res. 2023;328:115490.
    >> Share

  144. BALDINI V, Stefano RD, Rindi LV, Ahmed AO, et al
    Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2023;329:115488.
    >> Share

  145. GEBREEGZIABHERE Y, Habatmu K, Cella M, Alem A, et al
    Introducing an interview-based cognitive assessment tool for people with Schizophrenia in Ethiopia.
    Psychiatry Res. 2023;328:115474.
    >> Share

  146. SANCHEZ-TORRES AM, Garcia de Jalon E, Gil-Berrozpe GJ, Peralta V, et al
    Cognitive intraindividual variability, cognitive impairment and psychosocial functioning in first-episode psychosis patients.
    Psychiatry Res. 2023;328:115473.
    >> Share

  147. FORDHAM E, Gao CX, Filia K, O'Donoghue B, et al
    Social disadvantage in early psychosis and its effect on clinical presentation and service access, engagement and use.
    Psychiatry Res. 2023;328:115478.
    >> Share

  148. MAURUS I, Roell L, Lembeck M, Papazova I, et al
    Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial.
    Psychiatry Res. 2023;328:115480.
    >> Share

  149. INCHAUSTI L, Gorostiza I, Gonzalez Torres MA, Oraa R, et al
    The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use.
    Psychiatry Res. 2023;328:115475.
    >> Share

  150. FANG X, Gao C, Wu W, Hu X, et al
    The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional study.
    Psychiatry Res. 2023;328:115463.
    >> Share

  151. ZHANG J, Yang Y, Liu T, Shi Z, et al
    Functional connectivity in people at clinical and familial high risk for schizophrenia.
    Psychiatry Res. 2023;328:115464.
    >> Share

  152. SMITH ECC, Au E, Pereira S, Sharma E, et al
    Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review.
    Psychiatry Res. 2023;328:115472.
    >> Share

  153. LUCKHOFF HK, Asmal L, Smit R, Phahladira L, et al
    Sex, gender, and outcome in first-episode psychosis: The role of premorbid functioning.
    Psychiatry Res. 2023;328:115460.
    >> Share

  154. SEGAL SP, Rimes L, Badran L
    Crime and victimization outcomes following civil rights limits to the use of compulsory treatment.
    Psychiatry Res. 2023;327:115377.
    >> Share

  155. JOSHI YB, Gonzalez CE, Molina JL, MacDonald LR, et al
    Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders.
    Psychiatry Res. 2023;327:115215.
    >> Share

  156. XIE Y, Guan M, Wang Z, Ma Z, et al
    Alterations in brain connectivity patterns in schizophrenia patients with auditory verbal hallucinations during low frequency repetitive transcranial magnetic stimulation.
    Psychiatry Res. 2023;328:115457.
    >> Share

    August 2023
  157. KUUSKMAE C, Philips MA, Kilk K, Haring L, et al
    Kynurenine pathway dynamics in patients with schizophrenia spectrum disorders across the disease trajectory.
    Psychiatry Res. 2023;328:115423.
    >> Share

  158. CARRION RE, Auther AM, McLaughlin D, Adelsheim S, et al
    Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;328:115420.
    >> Share

  159. ZHANG Y, Lu Z, Sun Y, Zhang X, et al
    Predictive role of pulvinar in social functional outcome of schizophrenia.
    Psychiatry Res. 2023;327:115419.
    >> Share

  160. JOHANSSON M, Hjarthag F, Helldin L
    Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in schizophrenia.
    Psychiatry Res. 2023;328:115421.
    >> Share

  161. FEKIH-ROMDHANE F, Abassi B, Ghrissi F, Loch AA, et al
    Suicide risk among individuals at Ultra-High Risk (UHR) of psychosis in a developing North African country: A 12-month naturalistic prospective cohort study from the TRIP project.
    Psychiatry Res. 2023;327:115409.
    >> Share

  162. ALEKSANDROWICZ A, Kowalski J, Stefaniak I, Elert K, et al
    Cognitive correlates of auditory hallucinations in schizophrenia spectrum disorders.
    Psychiatry Res. 2023;327:115372.
    >> Share

  163. LIU X, Xu L, Gong J, Ye Q, et al
    The effect of high-dose accelerated continuous theta burst stimulation (cTBS) treatment on auditory verbal hallucinations (AVH): A pilot study.
    Psychiatry Res. 2023;326:115337.
    >> Share

  164. LOCH AA, Pinto MTC, Andrade JC, de Jesus LP, et al
    Plasma levels of neurotrophin 4/5, NGF and pro-BDNF influence transition to mental disorders in a sample of individuals at ultra-high risk for psychosis.
    Psychiatry Res. 2023;327:115402.
    >> Share

    July 2023
  165. HEMAGER N, Gregersen M, Christiani CJ, Hjorthoj C, et al
    Development of social functioning in preadolescent children at familial high-risk of schizophrenia or bipolar disorder - a 4-year follow-up study from age 7 to 11.
    Psychiatry Res. 2023;327:115397.
    >> Share

  166. DAI J, Zhang MZ, He QQ, Chen R, et al
    The emerging role of exosomes in Schizophrenia.
    Psychiatry Res. 2023;327:115394.
    >> Share

  167. KONDRATYEV NV, Alfimova MV, Kaleda VG, Lezheiko TV, et al
    Assessing the impact of the de novo SLC6A1 mutation in schizophrenia through a comprehensive case study.
    Psychiatry Res. 2023;327:115399.
    >> Share

  168. ZHANG T, Wei Y, Cui H, Tang X, et al
    Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
    Psychiatry Res. 2023;327:115385.
    >> Share

  169. WANG C, Tishler TA, Nuechterlein KH, Ellingson BM, et al
    Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics.
    Psychiatry Res. 2023;326:115364.
    >> Share

    June 2023
  170. CHEN X, Tan W, Cheng Y, Huang D, et al
    Polygenic risk for schizophrenia and the language network: Putative compensatory reorganization in unaffected siblings.
    Psychiatry Res. 2023;326:115319.
    >> Share

  171. PANARIELLO F, Zamparini M, Picchioni M, Nielssen OB, et al
    Exposure to violence in childhood and risk of violence in adult schizophrenia: Results from a multinational study.
    Psychiatry Res. 2023;326:115299.
    >> Share

  172. CHU RYK, Wei Y, Osborn DP, Ng VWS, et al
    Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades.
    Psychiatry Res. 2023;326:115287.
    >> Share

  173. OKADA H, Sawamura D, Kunita K, Ogasawara H, et al
    Prefrontal activation during simulated driving in people with schizophrenia: A functional near-infrared spectroscopy study.
    Psychiatry Res. 2023;326:115285.
    >> Share

    May 2023
  174. VEDDUM L, Greve AN, Gregersen M, Andreassen AK, et al
    A study of the genetic architecture of social responsiveness in families with parental schizophrenia or bipolar disorder and population-based controls.
    Psychiatry Res. 2023;326:115280.
    >> Share

  175. TATAR O, Abdel-Baki A, Dyachenko A, Bakouni H, et al
    Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study.
    Psychiatry Res. 2023;326:115276.
    >> Share

  176. LEE JJ, Piras E, Tamburini S, Bu K, et al
    Gut and oral microbiome modulate molecular and clinical markers of schizophrenia-related symptoms: A transdiagnostic, multilevel pilot study.
    Psychiatry Res. 2023;326:115279.
    >> Share

  177. SHADOWEN N, Meehan Z, Webb C, Fowles T, et al
    Early intervention in youth psychosis: Novel approaches to understanding change.
    Psychiatry Res. 2023;326:115269.
    >> Share

  178. COHN J
    Elaboration of some points in "The association of gender dysphoria with psychosis".
    Psychiatry Res. 2023;325:115264.
    >> Share

  179. LI Q, Gong Y, Cui Y, Cheng C, et al
    Efficacy of transcutaneous electrical acupoint stimulation for patients with first-episode schizophrenia: An 8-week, preliminary, randomized controlled trial.
    Psychiatry Res. 2023;325:115255.
    >> Share

  180. WOJTALIK JA, Brown WJ, Mesholam-Gately RI, Kotwani A, et al
    Predictors of treatment discontinuation during an 18-month multi-site randomized trial of Cognitive Enhancement Therapy for early course schizophrenia.
    Psychiatry Res. 2023;326:115254.
    >> Share

  181. CIAMPELLI S, Voppel AE, de Boer JN, Koops S, et al
    Combining automatic speech recognition with semantic natural language processing in schizophrenia.
    Psychiatry Res. 2023;325:115252.
    >> Share

  182. ZHANG H, Parola A, Zhou Y, Wang H, et al
    Linguistic markers of psychosis in Mandarin Chinese: Relations to theory of mind.
    Psychiatry Res. 2023;325:115253.
    >> Share

  183. REICH N, Delavari F, Schneider M, Thillainathan N, et al
    Multivariate patterns of disrupted sleep longitudinally predict affective vulnerability to psychosis in 22q11.2 Deletion Syndrome.
    Psychiatry Res. 2023;325:115230.
    >> Share

  184. SANCHEZ RUIZ JA, Coombes BJ, Pendegraft RS, Ozerdem A, et al
    Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors.
    Psychiatry Res. 2023;323:115174.
    >> Share

  185. BUCK B, Wingerson M, Chander A, Tauscher JS, et al
    A preliminary study examining terminology used by individuals with lived experience describing beliefs about being targeted or harmed by others.
    Psychiatry Res. 2023;323:115129.
    >> Share

    April 2023
  186. FUNG VSC, Chan JCY, Wong SCY, Wong CSM, et al
    Investigation of momentary negative symptoms in patients with early psychosis in daily life: An experience sampling study.
    Psychiatry Res. 2023;325:115234.
    >> Share

  187. TOLL A, Pechuan E, Berge D, Legido T, et al
    Factors associated with suicide attempts in first-episode psychosis during the first two years after onset.
    Psychiatry Res. 2023;325:115232.
    >> Share

  188. BENUTO LT, Done M, Zepeda M, Fitzgerald J, et al
    A systematic review of persons of color participation in first episode psychosis coordinated specialty care randomized controlled trials in North America.
    Psychiatry Res. 2023;325:115221.
    >> Share

  189. TROTTI RL, Parker DA, Sabatinelli D, Keshavan MS, et al
    Emotional scene processing in biotypes of psychosis.
    Psychiatry Res. 2023;324:115227.
    >> Share

  190. LU Z, Zhang Y, Sun Y, Liao Y, et al
    The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.
    Psychiatry Res. 2023;324:115226.
    >> Share

  191. O'CONNELL KS, Koch E, Lenk HC, Akkouh IA, et al
    Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia.
    Psychiatry Res. 2023;325:115217.
    >> Share

  192. DE THURAH L, Kiekens G, Sips R, Teixeira A, et al
    Using Experience Sampling Methods to support clinical management of psychosis: The perspective of people with lived experience.
    Psychiatry Res. 2023;324:115207.
    >> Share

  193. ELVEVAG B
    Reflections on measuring disordered thoughts as expressed via language.
    Psychiatry Res. 2023;322:115098.
    >> Share

  194. TONYALI A, Karacetin G, Ocakoglu BK, Atay A, et al
    Development and validation of Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) for Internet Gaming Disorder (IGD) and factor analytic assessment.
    Psychiatry Res. 2023;324:115187.
    >> Share

    March 2023
  195. FUSAR-POLI L, Prachason T, Erzin G, Pries LK, et al
    Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.
    Psychiatry Res. 2023;323:115184.
    >> Share

  196. GARRIDO-TORRES N, Alameda L, Suarez MLS, Rocha Gonzalez I, et al
    Corrigendum "Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain" [Psychiatry Res. 308 (2022) 114352].
    Psychiatry Res. 2023 Mar 27:115146. doi: 10.1016/j.psychres.2023.115146.
    >> Share

  197. XU H, Zhou Y, Wang J, Liang Z, et al
    Effect of HD-tDCS on white matter integrity and associated cognitive function in chronic schizophrenia: A double-blind, sham-controlled randomized trial.
    Psychiatry Res. 2023;324:115183.
    >> Share

  198. SUEN YN, Pang SWT, Cheung C, Wong TY, et al
    Impact of early negative symptom patterns on the long-term outcomes of patients with first-episode schizophrenia-spectrum disorders: A 12-year follow up study.
    Psychiatry Res. 2023;323:115180.
    >> Share

  199. POLETTI M, Pelizza L, Loas G, Azzali S, et al
    Anhedonia and suicidal ideation in young people with early psychosis: Further findings from the 2-year follow-up of the ReARMS program.
    Psychiatry Res. 2023;323:115177.
    >> Share

  200. TUCCI AA, Schroeder A, Noel C, Shvetz C, et al
    Social cognition in youth with a first-degree relative with schizophrenia: A systematic scoping review.
    Psychiatry Res. 2023;323:115173.
    >> Share

  201. PETKARI E
    Can we really define the effect of psychological interventions on Quality of Life for patients with schizophrenia based on the most recent meta-analysis in the field?
    Psychiatry Res. 2023 Mar 20:115149. doi: 10.1016/j.psychres.2023.115149.
    >> Share

  202. GOUSE BM, Boliver EE, Oblath R, Camacho L, et al
    Cannabis use among patients presenting to the emergency department for psychosis: Associations with restraint use, medication administration, psychiatric hospitalization, and repeat visits.
    Psychiatry Res. 2023;323:115151.
    >> Share

  203. AIREY ND, Taylor CDJ, Vikram A, Berry K, et al
    Trauma measures for use with psychosis populations: A systematic review of psychometric properties using COSMIN.
    Psychiatry Res. 2023;323:115163.
    >> Share

  204. MEDALIA A, Saperstein A, Javitt DC, Qian M, et al
    Feasibility and clinical utility of using the tone matching test for assessment of early auditory processing in schizophrenia.
    Psychiatry Res. 2023;323:115152.
    >> Share

  205. PALMA-ALVAREZ RF, Daigre C, Ros-Cucurull E, Perea-Ortueta M, et al
    Clinical features and factors related to lifetime suicidal ideation and suicide attempts in patients who have had substance-induced psychosis across their lifetime.
    Psychiatry Res. 2023;323:115147.
    >> Share

  206. LIN BD, Vermeulen JM, Bolhuis K, Chang X, et al
    Associations between genetic liabilities to smoking behavior and schizophrenia symptoms in patients with a psychotic disorder, their siblings and healthy controls.
    Psychiatry Res. 2023;323:115143.
    >> Share

  207. FIVEL L, Mondino M, Brunelin J, Haesebaert F, et al
    Basic auditory processing and its relationship with symptoms in patients with schizophrenia: A systematic review.
    Psychiatry Res. 2023;323:115144.
    >> Share

  208. XIE M, Cai J, Liu Y, Wei W, et al
    Association between childhood trauma and white matter deficits in first-episode schizophrenia.
    Psychiatry Res. 2023;323:115111.
    >> Share

  209. VEDDUM L, Gregersen M, Andreassen AK, Knudsen CB, et al
    Social responsiveness in families with parental schizophrenia or bipolar disorder-The Danish High Risk and Resilience Study.
    Psychiatry Res. 2023;323:115140.
    >> Share

  210. TAVARES VDO, Rossell SL, Schuch FB, Herring M, et al
    Effects of exercise on cognitive functioning in adults with serious mental illness: A meta analytic review.
    Psychiatry Res. 2023;321:115081.
    >> Share

  211. NIZNIKIEWICZ MA
    From communication dysfunction to treatment options in serious mental illness.
    Psychiatry Res. 2023;321:115062.
    >> Share

  212. DO KQ
    Bridging the gaps towards precision psychiatry: Mechanistic biomarkers for early detection and intervention.
    Psychiatry Res. 2023;321:115064.
    >> Share

  213. DUBOURG L, Kojovic N, Eliez S, Schaer M, et al
    Visual processing of complex social scenes in 22q11.2 deletion syndrome: Relevance for negative symptoms.
    Psychiatry Res. 2023;321:115074.
    >> Share

  214. CAI J, Li L, Shao T, Sun M, et al
    Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.
    Psychiatry Res. 2023;322:115138.
    >> Share

    February 2023
  215. PONCE-CORREA F, Caqueo-Urizar A, Berrios R, Escobar-Soler C, et al
    Defining recovery in schizophrenia: A review of outcome studies.
    Psychiatry Res. 2023;322:115134.
    >> Share

  216. WANG Y, Wang J, Su W, Hu H, et al
    Symptom-circuit mappings of the schizophrenia connectome.
    Psychiatry Res. 2023;323:115122.
    >> Share

  217. MA X, Yang WFZ, Zheng W, Li Z, et al
    Neuronal dysfunction in individuals at early stage of schizophrenia, A resting-state fMRI study.
    Psychiatry Res. 2023;322:115123.
    >> Share

  218. PERALTA V, de Jalon EG, Moreno-Izco L, Peralta D, et al
    A clinical staging model of psychotic disorders based on a long-term follow-up of first-admission psychosis: A validation study.
    Psychiatry Res. 2023;322:115109.
    >> Share

  219. ROMEO B, Willaime L, Rari E, Benyamina A, et al
    Efficacy of 5-HT2A antagonists on negative symptoms in patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2023;321:115104.
    >> Share

  220. STEFFENSEN NL, Hemager N, Bundgaard AF, Gantriis DL, et al
    Affective lability in parents with schizophrenia or bipolar disorder and their co-parents - The Danish High Risk and Resilience Study VIA 7.
    Psychiatry Res. 2023;321:115092.
    >> Share

  221. DUDLEY R, Denton S, Mathewson J, Pervez S, et al
    Prevalence of multisensory hallucinations in people at risk of transition to psychosis.
    Psychiatry Res. 2023;322:115091.
    >> Share

  222. LUO G, Li Y, Yao C, Li M, et al
    Duration of untreated illness and clinical correlates in first-episode and drug-naive patients with major depressive disorder.
    Psychiatry Res. 2023;320:115056.
    >> Share

  223. AAS M, Ueland T, Lagerberg TV, Melle I, et al
    Retrospectively assessed childhood trauma experiences are associated with illness severity in mental disorders adjusted for symptom state.
    Psychiatry Res. 2023;320:115045.
    >> Share

  224. OLAYA B, Moneta MV, Plana-Ripoll O, Haro JM, et al
    Association between mental disorders and mortality: A register-based cohort study from the region of Catalonia.
    Psychiatry Res. 2023;320:115037.
    >> Share

    January 2023
  225. KIM AM, Sohn JH
    The impact of the Mental Health Act revision for deinstitutionalization in Korea on the crime rate of people with schizophrenia.
    Psychiatry Res. 2023;321:115089.
    >> Share

  226. TAN EJ, Neill E, Kleiner JL, Rossell SL, et al
    Depressive symptoms are specifically related to speech pauses in schizophrenia spectrum disorders.
    Psychiatry Res. 2023;321:115079.
    >> Share

  227. BORKENT J, Ioannou M, Folkertsma TS, Wardenaar KJ, et al
    Serum free thiols in recently diagnosed patients with schizophrenia spectrum disorder: A potentially useful biomarker of oxidative stress.
    Psychiatry Res. 2023;321:115075.
    >> Share

  228. ESPOSITO CM, Biagianti B, D'Agostino A, Dell'Osso B, et al
    First episode psychosis during the Covid-19 pandemic in Milan, Italy: Diagnostic outcomes at 1-year follow-up.
    Psychiatry Res. 2023;321:115068.
    >> Share

  229. SONG M, Liu Y, Zhou J, Shi H, et al
    Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
    Psychiatry Res. 2023;321:115070.
    >> Share

  230. RICCI V, Ceci F, Di Carlo F, Di Muzio I, et al
    First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
    Psychiatry Res. 2023;320:115053.
    >> Share

  231. MINOR KS, Lundin NB, Myers EJ, Fernandez-Villardon A, et al
    Automated measures of speech content and speech organization in schizophrenia: Test-retest reliability and generalizability across demographic variables.
    Psychiatry Res. 2023;320:115048.
    >> Share


  232. Letter to Editor regarding "Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain".
    Psychiatry Res. 2023;322:115016.
    >> Share

  233. KULKARNI J
    Estrogen - A key neurosteroid in the understanding and treatment of mental illness in women.
    Psychiatry Res. 2023;319:114991.
    >> Share

  234. MOTA NB
    How can computational tools help to understand language patterns in mental suffering considering social diversity.
    Psychiatry Res. 2023;319:114995.
    >> Share

    December 2022
  235. DELISI LE
    Brain plasticity, language anomalies, genetic risk and the patient with schizophrenia: Trajectory of change over a lifetime. A commentary.
    Psychiatry Res. 2022;320:115034.
    >> Share

  236. GALDERISI S
    Negative symptoms of schizophrenia: Trying to answer unanswered research questions.
    Psychiatry Res. 2022;320:115043.
    >> Share

  237. LI L, Rami FZ, Lee BM, Kim WS, et al
    Predictors of full recovery in patients with early stage schizophrenia spectrum disorders.
    Psychiatry Res. 2022;320:115035.
    >> Share

  238. JIN Y, Tong J, Huang Y, Shi D, et al
    Effectiveness of accelerated intermittent theta burst stimulation for social cognition and negative symptoms among individuals with schizophrenia: A randomized controlled trial.
    Psychiatry Res. 2022;320:115033.
    >> Share

  239. PENA-GARIJO J, Lacruz M, Masanet MJ, Palop-Grau A, et al
    Specific facial emotion recognition deficits across the course of psychosis: A comparison of individuals with low-risk, high-risk, first-episode psychosis and multi-episode schizophrenia-spectrum disorders.
    Psychiatry Res. 2022;320:115029.
    >> Share

  240. STOROSUM BWC, Mattila T, Wohlfarth TD, Gispen-de Wied CC, et al
    Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies.
    Psychiatry Res. 2022;320:114997.
    >> Share

  241. ELLINI S, Romdhane IB, Bougacha D, Abassi A, et al
    COVID-19 induced psychosis: A case report.
    Psychiatry Res. 2022;320:115009.
    >> Share

  242. GARRIDO-TORRES N, Alameda L, Rocha-Gonzalez I, Canal-Rivero M, et al
    Response to the letter to editor regarding "Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain".
    Psychiatry Res. 2022;322:115008.
    >> Share

  243. MANNARINI S, Taccini F, Sato I, Rossi AA, et al
    Understanding stigma toward schizophrenia.
    Psychiatry Res. 2022;318:114970.
    >> Share

  244. SOMMER IE, N de Boer J
    How to reap the benefits of language for psychiatry.
    Psychiatry Res. 2022;318:114932.
    >> Share

    November 2022
  245. ROSEN RL, Ramasubramani RS, Benowitz NL, Gandhi KK, et al
    Caffeine levels and dietary intake in smokers with schizophrenia and bipolar disorder.
    Psychiatry Res. 2022;319:114989.
    >> Share

  246. BASSETT AS
    Clinical genetics of schizophrenia and related neuropsychiatric disorders.
    Psychiatry Res. 2022;319:114992.
    >> Share

  247. DUDLEY R, Watson F, O'Grady L, Aynsworth C, et al
    Prevalence and nature of multi-sensory and multi-modal hallucinations in people with first episode psychosis.
    Psychiatry Res. 2022;319:114988.
    >> Share

  248. LAHTI AC
    Discovery of early schizophrenia through neuroimaging.
    Psychiatry Res. 2022;322:114993.
    >> Share

  249. CELLA M, Sedgwick O, Lawrence M, Grant N, et al
    Evaluating the mechanisms of social cognition intervention in schizophrenia: A proof-of-concept trial.
    Psychiatry Res. 2022;319:114963.
    >> Share

  250. TAO TJ, Hui CLM, Hui PWM, Ho ECN, et al
    Working memory deterioration as an early warning sign for relapse in remitted psychosis: A one-year naturalistic follow-up study.
    Psychiatry Res. 2022;319:114976.
    >> Share

  251. XIE Y, Guan M, Cai Y, Wang Z, et al
    Impact of low-frequency repetitive transcranial magnetic stimulation on functional network connectivity in schizophrenia patients with auditory verbal hallucinations.
    Psychiatry Res. 2022;320:114974.
    >> Share

  252. GOODING DC
    Social anhedonia and other indicators of risk for schizophrenia: Theory and inquiry.
    Psychiatry Res. 2022;319:114966.
    >> Share

  253. CHA M, Al-Chalabi N, Qian J, Chaudhary Z, et al
    Concordance between the Columbia-Suicide Severity Rating Scale and Beck Scale for Suicide Ideation in assessing suicide behaviour in young adults with schizophrenia spectrum disorders.
    Psychiatry Res. 2022;319:114965.
    >> Share

  254. LV H, Li J, Gao K, Zeng L, et al
    Identification of genetic loci that overlap between schizophrenia and metabolic syndrome.
    Psychiatry Res. 2022;318:114947.
    >> Share

  255. RUIZ-DELGADO I, Moreno-Kustner B, Garcia-Medina M, Barrigon ML, et al
    Is Metacognitive Training effective for improving neurocognitive function in patients with a recent onset of psychosis?
    Psychiatry Res. 2022;318:114941.
    >> Share

  256. SCHWAB SG
    Genetic variation and susceptibility to schizophrenia: Work in progress.
    Psychiatry Res. 2022;318:114949.
    >> Share

  257. ZHANG Q, Huo JH, Guo L, Wang L, et al
    Common and rare variants within SP4 exert distinct molecular mechanisms contributing to the risk of schizophrenia.
    Psychiatry Res. 2022;318:114948.
    >> Share

  258. LU W, Srijeyanthan J, Mueser KT, Yanos PT, et al
    Predictors of undocumented PTSD in persons using public mental health services.
    Psychiatry Res. 2022;317:114892.
    >> Share

  259. KIM WS, Heo DW, Shen J, Tsogt U, et al
    Altered functional connectivity in psychotic disorder not otherwise specified.
    Psychiatry Res. 2022;317:114871.
    >> Share

  260. LANGLOIS T, Sanchez-Rodriguez R, Bourcier A, Lamy P, et al
    "Accept voices(c)" group intervention for the management of auditory verbal hallucinations-results at 6 and 12 months.
    Psychiatry Res. 2022;317:114860.
    >> Share

  261. RIHAL V, Khan H, Kaur A, Singh TG, et al
    Therapeutic and mechanistic intervention of vitamin D in neuropsychiatric disorders.
    Psychiatry Res. 2022;317:114782.
    >> Share

    October 2022
  262. ZHANG T, Zeng J, Wei Y, Ye J, et al
    Changes in inflammatory balance correlates with conversion to psychosis among individuals at clinical high-risk: A prospective cohort study.
    Psychiatry Res. 2022;318:114938.
    >> Share

  263. SCHELIGA S, Schwank R, Scholle R, Habel U, et al
    A neural mechanism underlying predictive visual motion processing in patients with schizophrenia.
    Psychiatry Res. 2022;318:114934.
    >> Share

  264. CUESTA MJ, Sanchez-Torres AM, Moreno-Izco L, Garcia de Jalon E, et al
    Neurocognitive correlates of the varied domains of outcomes at 20 year follow-up of first-episode psychosis.
    Psychiatry Res. 2022;318:114933.
    >> Share

  265. ENDRES D, Lerchenmuller V, Runge K, von Zedtwitz K, et al
    Anti-astrocytic autoantibody patterns in the cerebrospinal fluid of patients with depression and psychosis.
    Psychiatry Res. 2022;317:114905.
    >> Share

  266. GIZDIC A, Baxter T, Barrantes-Vidal N, Park S, et al
    Loneliness and psychosocial predictors of psychosis-proneness during COVID-19: Preliminary findings from Croatia.
    Psychiatry Res. 2022;317:114900.
    >> Share

  267. DEAN B, Thomas EHX, Bozaoglu K, Tan EJ, et al
    Evidence that a working memory cognitive phenotype within schizophrenia has a unique underlying biology.
    Psychiatry Res. 2022;317:114873.
    >> Share

  268. PELIZZA L, Quattrone E, Leuci E, Paulillo G, et al
    Anxious-depressive symptoms after a first episode of schizophrenia: Response to treatment and psychopathological considerations from the 2-year "Parma Early Psychosis" program.
    Psychiatry Res. 2022;317:114887.
    >> Share

  269. BARLATI S, Nibbio G, Bianchi F, Gigli EBL, et al
    Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting.
    Psychiatry Res. 2022;317:114878.
    >> Share

  270. DOKUZ G, Kani AS, Uysal O, Kuscu MK, et al
    The impact of childhood trauma and daily life experiences on emotional and psychotic symptom intensity in psychosis: An experience sampling study.
    Psychiatry Res. 2022;317:114872.
    >> Share

    September 2022
  271. UPTHEGROVE R
    From co-morbidity to transdiagnostic potential and novel immunotherapies for psychosis.
    Psychiatry Res. 2022;317:114866.
    >> Share

  272. MORITZ S, Goritz AS, Franz C, Sibilis A, et al
    Whodunit - A novel video-based task for the measurement of jumping to conclusions in the schizophrenia spectrum.
    Psychiatry Res. 2022;317:114862.
    >> Share

  273. WALKER E
    The permeable boundary between biological and psychological processes in the origins of psychosis.
    Psychiatry Res. 2022;317:114853.
    >> Share

  274. MALASPINA D
    A sisters search for the seeds of psychosis.
    Psychiatry Res. 2022;317:114846.
    >> Share

  275. SNELLEKSZ M, Rossell SL, Gibbons A, Nithianantharajah J, et al
    Evidence that the frontal pole has a significant role in the pathophysiology of schizophrenia.
    Psychiatry Res. 2022;317:114850.
    >> Share

  276. YAO L, Liu H, Tian X
    Medication adherence among community-dwelling schizophrenia patients during the COVID-19 pandemic: A cross-sectional study.
    Psychiatry Res. 2022;317:114841.
    >> Share

    August 2022
  277. KOOPOWITZ SM, Cotton SM, Uhlmann A, Thomas KGF, et al
    Executive function in methamphetamine users with and without psychosis.
    Psychiatry Res. 2022;317:114820.
    >> Share

  278. BIZUMIC B, Gunningham B, Christensen BK
    Prejudice towards people with mental illness, schizophrenia, and depression among mental health professionals and the general population.
    Psychiatry Res. 2022;317:114817.
    >> Share

  279. EATON WW, Rodriguez KM, Thomas MA, Johnson J, et al
    Immunologic profiling in schizophrenia and rheumatoid arthritis.
    Psychiatry Res. 2022;317:114812.
    >> Share

  280. BARANOVA A, Cao H, Zhang F
    Severe COVID-19 increases the risk of schizophrenia.
    Psychiatry Res. 2022;317:114809.
    >> Share

  281. MCCARTHY JM, Wood AJ, Shinners MG, Heinrich H, et al
    Pilot development and feasibility of telehealth Community Reinforcement and Family Training (CRAFT) for early psychosis and substance use.
    Psychiatry Res. 2022;317:114804.
    >> Share

  282. HU M, Xia Y, Zong X, Sweeney JA, et al
    Risperidone-induced changes in DNA methylation in peripheral blood from first-episode schizophrenia patients parallel changes in neuroimaging and cognitive phenotypes.
    Psychiatry Res. 2022;317:114789.
    >> Share

  283. LYNCH DA, Brown M, Saperstein A, Stefancic A, et al
    Assessing metamotivation in schizophrenia: A pilot study of the Brief Regulation of Motivation Scale (BRoMS).
    Psychiatry Res. 2022;317:114799.
    >> Share

  284. LI Z, Chen X
    Comprehensive analysis of shared genetic loci between hippocampal volume and schizophrenia.
    Psychiatry Res. 2022;316:114795.
    >> Share

  285. TIKKANEN V, Siira V, Wahlberg KE, Hakko H, et al
    Deficits in adolescent social functioning, dysfunctional family processes and genetic risk for schizophrenia spectrum disorders as risk factors for later psychiatric morbidity of adoptees.
    Psychiatry Res. 2022;316:114793.
    >> Share

  286. LIU CM, Liu CC, Hsieh MH, Hwang TJ, et al
    The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis.
    Psychiatry Res. 2022;316:114775.
    >> Share

  287. HERPERTZ J, Richter MF, Barkhau C, Storck M, et al
    Symptom monitoring based on digital data collection during inpatient treatment of schizophrenia spectrum disorders - A feasibility study.
    Psychiatry Res. 2022;316:114773.
    >> Share

  288. CAI H, Zeng C, Zhang X, Liu Y, et al
    Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study.
    Psychiatry Res. 2022;316:114762.
    >> Share

  289. KOOL L, Oranje B, Meijs H, De Wilde B, et al
    Event-related potentials and use of psychotropic medication in major psychiatric disorders.
    Psychiatry Res. 2022;314:114637.
    >> Share

  290. PUJOL N, Berge D, Mane A, Bioque M, et al
    The influence of modifiable cardiovascular risk factors on cognition, functioning, and inflammatory markers in first-episode psychosis: Results from a 2-year follow-up study.
    Psychiatry Res. 2022;316:114760.
    >> Share

    July 2022
  291. SALEHI A, Namaei P, TaghaviZanjani F, Bagheri S, et al
    Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial.
    Psychiatry Res. 2022;316:114737.
    >> Share

  292. DESAI SS, Nguyen AL, Bernstein GA
    Letter to editor: Case report of long COVID-19 with psychosis in a child.
    Psychiatry Res. 2022;316:114743.
    >> Share

  293. SEEMAN MV
    Sex/Gender differences in schizophrenia: Thinking back and thinking forward.
    Psychiatry Res. 2022;316:114738.
    >> Share

  294. DADERWAL MC, Sreeraj VS, Suhas S, Rao NP, et al
    Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.
    Psychiatry Res. 2022;316:114731.
    >> Share

  295. GALLIOT G, Sanchez-Rodriguez R, Belloc A, Phulpin H, et al
    Is clinical insight a determinant factor of subjective recovery in persons living with schizophrenia or schizoaffective disorders?
    Psychiatry Res. 2022;316:114726.
    >> Share

  296. PARK HJ, Kang WS, Oh M, Kim JW, et al
    Association of the promoter haplotype in CDK5 gene with schizophrenia in a Korean population.
    Psychiatry Res. 2022;316:114723.
    >> Share

  297. RIBOLSI M, Albergo G, Fiori Nastro F, Pelle M, et al
    Autistic symptomatology in UHR patients: A preliminary report.
    Psychiatry Res. 2022;313:114634.
    >> Share

  298. NGUYEN T, Frayne J, Watson S, Lebedevs T, et al
    Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital.
    Psychiatry Res. 2022;313:114614.
    >> Share

    June 2022
  299. DIAGO M, Vila-Badia R, Serra-Arumi C, Butjosa A, et al
    Emotional abuse and perceived stress: The most relevant factors in suicide behavior in first-episode psychosis patients.
    Psychiatry Res. 2022;315:114699.
    >> Share

  300. JEREMIAN R, Malinowski A, Chaudhary Z, Srivastava A, et al
    Epigenetic age dysregulation in individuals with bipolar disorder and schizophrenia.
    Psychiatry Res. 2022;315:114689.
    >> Share

  301. RAMAIN J, Conus P, Golay P
    Grouping affective psychoses in early intervention: Justification for specific treatment guidelines.
    Psychiatry Res. 2022;314:114690.
    >> Share

  302. ZARBO C, Agosta S, Casiraghi L, De Novellis A, et al
    Assessing adherence to and usability of Experience Sampling Method (ESM) and actigraph in patients with Schizophrenia Spectrum Disorder: A mixed-method study.
    Psychiatry Res. 2022;314:114675.
    >> Share

    May 2022
  303. LI Z, Li X, Jin M, Liu Y, et al
    Identification of potential biomarkers and their correlation with immune infiltration cells in schizophrenia using combinative bioinformatics strategy.
    Psychiatry Res. 2022;314:114658.
    >> Share

  304. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: An updated systematic review and meta-analysis.
    Psychiatry Res. 2022;314:114656.
    >> Share

  305. KIRSCHENBAUM MA, Lopez LV, de Filippis R, Ali AF, et al
    Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool.
    Psychiatry Res. 2022;314:114647.
    >> Share

  306. BHATTACHARYYA U, Bhatia T, Deshpande SN, Thelma BK, et al
    Genetic variations in evolutionary accelerated regions disrupt cognition in schizophrenia.
    Psychiatry Res. 2022;314:114586.
    >> Share

  307. XU L, Hao D, Wei Y, Cui H, et al
    Effect of cognitive insight on clinical insight from pre-morbid to early psychosis stages.
    Psychiatry Res. 2022;313:114613.
    >> Share

  308. CAO X, Chen S, Xu H, Wang Q, et al
    Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study.
    Psychiatry Res. 2022;313:114616.
    >> Share

  309. LONG J, Tian L, Baranova A, Cao H, et al
    Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia.
    Psychiatry Res. 2022;312:114588.
    >> Share

  310. KATZ IR, Szymanski BR, Marder SR, Shotwell A, et al
    Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications.
    Psychiatry Res. 2022;313:114590.
    >> Share

    April 2022
  311. THAI H, Robertson C, Friberg L, Hatko A, et al
    WHODAS 2.0: Associations of functional disability with sex, age, and length of care in outpatients with schizophrenia-spectrum disorders.
    Psychiatry Res. 2022;313:114583.
    >> Share

  312. MARTINS PS, Caldas F, Oliveira C, Mota J, et al
    A 10-year mirror-image study of effectiveness and cost of long-acting paliperidone palmitate injectable in patients with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2022;312:114581.
    >> Share

  313. LI X, Yuan X, Pang L, Zhang S, et al
    nThe effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-naive, first episode schizophrenia patients.
    Psychiatry Res. 2022;313:114582.
    >> Share

  314. XU Y, Cai Z, Fang C, Zheng J, et al
    Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily care: A meta-analysis.
    Psychiatry Res. 2022;312:114560.
    >> Share

  315. OUYANG H, Huang M, Chen S, Wu X, et al
    Peripheral lower triiodothyronine levels related to interleukin-6 in patients with first-episode schizophrenia.
    Psychiatry Res. 2022;312:114546.
    >> Share

  316. WELCH KG, Stiles BJ, Palsson OS, Meyer-Kalos PS, et al
    The use of diary methods to evaluate daily experiences in first-episode psychosis.
    Psychiatry Res. 2022;312:114548.
    >> Share

  317. GONZALEZ-RODRIGUEZ A, Monreal JA, Porras-Segovia A, Cervilla JA, et al
    Psychometric instruments for the assessment of depressive symptoms in patients with delusional disorder: A systematic review.
    Psychiatry Res. 2022;310:114435.
    >> Share

    March 2022
  318. JAISWAL N, Kar SK, Gupta PK
    Comments on "High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial".
    Psychiatry Res. 2022;312:114532.
    >> Share

  319. PANDOLFO G, Genovese G, Bruno A, Campolo D, et al
    Advanced glycation end-products and advanced oxidation protein products in schizophrenia.
    Psychiatry Res. 2022;311:114527.
    >> Share

  320. LI J, Zhang X, Jiang J, Zhang B, et al
    Comparison of electroconvulsive therapy and magnetic seizure therapy in schizophrenia: Structural changes/neuroplasticity.
    Psychiatry Res. 2022;312:114523.
    >> Share

  321. BORNHEIMER LA, Li Verdugo J, Holzworth J, Im V, et al
    Modifying a cognitive behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health.
    Psychiatry Res. 2022;311:114505.
    >> Share

  322. XU X, Shao G, Zhang X, Hu Y, et al
    The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis.
    Psychiatry Res. 2022;311:114500.
    >> Share

  323. RAMMOUZ I, Bouri S, Merzouki M, Berraho MA, et al
    Reliability of self-report of cannabis use among patients with schizophrenia.
    Psychiatry Res. 2022;311:114491.
    >> Share

  324. KEMPPAINEN A, Lindgren M, Suvisaari J, Kieseppa T, et al
    Adverse childhood experiences and social and occupational functioning in first-episode psychosis - A one year follow - up.
    Psychiatry Res. 2022;311:114502.
    >> Share

  325. MUNIR K, Oner O, Kerala C, Rustamov I, et al
    Social distance and stigma towards persons with serious mental illness among medical students in five European Central Asia countries.
    Psychiatry Res. 2022;309:114409.
    >> Share

    February 2022
  326. GOHARI E, Moore RC, Depp CA, Ackerman RA, et al
    Momentary severity of psychotic symptoms predicts overestimation of competence in domains of everyday activities and work in schizophrenia: An ecological momentary assessment study.
    Psychiatry Res. 2022;310:114487.
    >> Share

  327. LIU Y, Jia LN, Wu H, Jiang W, et al
    Adjuvant electroconvulsive therapy with antipsychotics is associated with improvement in auditory mismatch negativity in schizophrenia.
    Psychiatry Res. 2022;311:114484.
    >> Share

  328. COWAN T, Cohen AS, Raugh IM, Strauss GP, et al
    Ambulatory audio and video recording for digital phenotyping in schizophrenia: Adherence & data usability.
    Psychiatry Res. 2022;311:114485.
    >> Share

  329. SANTESTEBAN-ECHARRI O, Sandel D, Liu L, Bearden CE, et al
    Family history of psychosis in youth at clinical high risk: A replication study.
    Psychiatry Res. 2022;311:114480.
    >> Share

  330. MORIKAWA R, Watanabe Y, Igeta H, Arta RK, et al
    Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis.
    Psychiatry Res. 2022;310:114481.
    >> Share

  331. RODRIGUEZ M, Knizkova K, Kerkova B, Sironova A, et al
    The relationships between cognitive reserve, cognitive functioning and quality of life in first-episode schizophrenia spectrum disorders.
    Psychiatry Res. 2022;310:114479.
    >> Share

  332. LEE HS, Rast C, Shenoy S, Dean D, et al
    A meta-analytic review of transcranial direct current stimulation (tDCS) on general psychopathology symptoms of schizophrenia; immediate improvement followed by a return to baseline.
    Psychiatry Res. 2022;310:114471.
    >> Share

  333. SONG W, Lin GN, Yu S, Zhao M, et al
    Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality.
    Psychiatry Res. 2022;310:114453.
    >> Share

  334. TAN EJ, Toh WL, Rossell SL
    Examining relationships between state and trait psychotic symptoms and quality of life in schizophrenia spectrum disorders.
    Psychiatry Res. 2022;310:114450.
    >> Share

  335. LOPEZ-NAVARRO E, Fonseca-Pedrero E, Errasti J, Al-Halabi S, et al
    Mindfulness improves theory of mind in people experiencing psychosis: A pilot randomized clinical trial.
    Psychiatry Res. 2022;310:114440.
    >> Share

  336. GOH XX, Tang PY, Tee SF
    Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2022;309:114429.
    >> Share

  337. SCHWARTZ EK, Le TP, Cohen AS
    Sharing positive events: Ecological momentary assessment of emotion regulation via social capitalization in schizotypy.
    Psychiatry Res. 2022;308:114377.
    >> Share

  338. GROENMAN AP, van der Werf S, Geurts HM
    Subjective cognition in adults with common psychiatric classifications; a systematic review.
    Psychiatry Res. 2022;308:114374.
    >> Share

    January 2022
  339. JEONG JH, Kim SW, Lee BJ, Kim JJ, et al
    The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: Results of a 1-year longitudinal follow-up prospective cohort study.
    Psychiatry Res. 2022;310:114420.
    >> Share

  340. BARTOLI F, Cavaleri D, Callovini T, Riboldi I, et al
    Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study.
    Psychiatry Res. 2022;309:114405.
    >> Share

  341. LUNDIN NB, Jones MN, Myers EJ, Breier A, et al
    Semantic and phonetic similarity of verbal fluency responses in early-stage psychosis.
    Psychiatry Res. 2022;309:114404.
    >> Share

  342. XIE Y, He Y, Guan M, Wang Z, et al
    Low-frequency rTMS treatment alters the topographical organization of functional brain networks in schizophrenia patients with auditory verbal hallucination.
    Psychiatry Res. 2022;309:114393.
    >> Share

  343. RAULT O, Lamothe H, Pelissolo A
    Therapeutic use of virtual reality relaxation in schizophrenia: A pilot study.
    Psychiatry Res. 2022;309:114389.
    >> Share

  344. VERDOUX H, Sibert A, Quiles C
    Trauma and resistance to antipsychotic treatment in schizophrenia: A narrative review.
    Psychiatry Res. 2022;309:114392.
    >> Share

  345. MORAN LV, Tsang ES, Ongur D, Hsu J, et al
    Geographical variation in hospitalization for psychosis associated with cannabis use and cannabis legalization in the United States: Submit to: Psychiatry Research.
    Psychiatry Res. 2022;308:114387.
    >> Share

  346. SINGH A, Kumar V, Pathak H, Jacob AA, et al
    Effect of antipsychotic dose reduction on cognitive function in schizophrenia.
    Psychiatry Res. 2022;308:114383.
    >> Share

  347. GANDHI A, Mote J, Fulford D
    A transdiagnostic meta-analysis of physical and social Anhedonia in major depressive disorder and schizophrenia spectrum disorders.
    Psychiatry Res. 2022;309:114379.
    >> Share

    December 2021
  348. LABONTE C, Zhand N, Park A, Harvey PD, et al
    Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation.
    Psychiatry Res. 2021;308:114382.
    >> Share

  349. GICAS KM, Parmar PK, Fabiano GF, Mashhadi F, et al
    Substance-induced psychosis and cognitive functioning: A systematic review.
    Psychiatry Res. 2021;308:114361.
    >> Share

  350. GARRIDO-TORRES N, Suarez-Suarez ML, Rocha-Gonzalez I, Alameda L, et al
    Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain.
    Psychiatry Res. 2021;308:114352.
    >> Share

  351. VERU F, MacDonald K, Malla A, Pruessner M, et al
    The effects of childhood adversity on treatment delays and its components in first-episode psychosis.
    Psychiatry Res. 2021;308:114341.
    >> Share

  352. LAVAUD P, McMahon K, Sanchez Rico M, Hanon C, et al
    Long-term care utilization within older adults with schizophrenia: Associated factors in a multicenter study.
    Psychiatry Res. 2021;308:114339.
    >> Share

  353. LIU X, Wang D, Fan R, Wang R, et al
    Life expectancy and potential years of life lost for schizophrenia in western China.
    Psychiatry Res. 2021;308:114330.
    >> Share

  354. LOCKWOOD L, Miller B, Youssef NA
    Epigenetics and first-episode psychosis: A systematic review.
    Psychiatry Res. 2021;307:114325.
    >> Share

  355. THOMPSON EC, Visser KF, Schiffman J, Spirito A, et al
    Preliminary evidence supporting the practice of psychosis-risk screening within an inpatient psychiatric setting serving adolescents.
    Psychiatry Res. 2021;307:114322.
    >> Share

  356. LEE S, Schwartz S
    Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies.
    Psychiatry Res. 2021;306:114277.
    >> Share

    November 2021
  357. LOCH AA, Mota NB, Rossler W, Gattaz WF, et al
    Exacerbation of psychosis risk during the COVID-19 pandemic: The disproportionate impact on the lower income population.
    Psychiatry Res. 2021;307:114319.
    >> Share

  358. ALLIENDE LM, Czepielewski LS, Aceituno D, Castaneda CP, et al
    Gender, age and geographical representation over the past 50 years of schizophrenia research.
    Psychiatry Res. 2021;307:114279.
    >> Share

  359. FERNANDEZ DK, Deane FP, Vella SA
    Effects of online continuum and categorical belief manipulations on schizophrenia stigma, help-seeking, and help-provision.
    Psychiatry Res. 2021;307:114293.
    >> Share

  360. CHEN S, Tang Y, Fan X, Qiao Y, et al
    The role of white matter abnormality in the left anterior corona radiata: In relation to formal thought disorder in patients with schizophrenia.
    Psychiatry Res. 2021;307:114302.
    >> Share

  361. GOU N, Xiang Y, Zhou J, Zhang S, et al
    Identification of violent patients with schizophrenia using a hybrid machine learning approach at the individual level.
    Psychiatry Res. 2021;306:114294.
    >> Share

  362. LAI M, Hegde R, Kelly S, Bannai D, et al
    Investigating sleep spindle density and schizophrenia: A meta-analysis.
    Psychiatry Res. 2021;307:114265.
    >> Share

  363. BARR SM, Roberts D, Thakkar KN
    Psychosis in transgender and gender non-conforming individuals: A review of the literature and a call for more research.
    Psychiatry Res. 2021;306:114272.
    >> Share

  364. LYU J, Zhang J
    Suicide means, timing, intent and behavior characteristics of the suicides with schizophrenia.
    Psychiatry Res. 2021;306:114267.
    >> Share

  365. RUSSO M, Consoli S, De Rosa MA, Calisi D, et al
    A case of Sars-Cov-2-related mania with prominent psychosis>.
    Psychiatry Res. 2021;306:114266.
    >> Share

  366. GALLOS IK, Mantonakis L, Spilioti E, Kattoulas E, et al
    The relation of integrated psychological therapy to resting state functional brain connectivity networks in patients with schizophrenia.
    Psychiatry Res. 2021;306:114270.
    >> Share

  367. SANTOS MJ, Ferreira TF, Sequeira M, Trancas B, et al
    Chronic hallucinatory psychosis presenting with olfactory hallucinations: A case report.
    Psychiatry Res. 2021;305:114262.
    >> Share

  368. SAHYOUNI C, Hefazi E
    Clozapine induced pericarditis: A case report.
    Psychiatry Res. 2021;305:114250.
    >> Share

  369. SHROITMAN NK, Peles E, Even-Tov S, Schreiber S, et al
    False-positive fentanyl screening kit results during treatment with long term injectable risperidone (Risperdal-Consta).
    Psychiatry Res. 2021;305:114246.
    >> Share

  370. RICHARDSON N, Greenway SC, Bousman CA
    Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
    Psychiatry Res. 2021;305:114247.
    >> Share

  371. BRASSO C, Cisotto M, Ghirardini C, Pennazio F, et al
    Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward.
    Psychiatry Res. 2021;305:114214.
    >> Share

  372. GROT S, Giguere CE, Smine S, Mongeau-Perusse V, et al
    Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.
    Psychiatry Res. 2021;305:114199.
    >> Share

  373. MILLER BJ, McCall WV, McEvoy JP, Lu XY, et al
    Insomnia and inflammation in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Psychiatry Res. 2021;305:114195.
    >> Share

    October 2021
  374. MENON V, Suhas S, Sethi MIS, Varadharajan N, et al
    Comments on the paper published by Lyu et al on Risk Factors for Suicide in People with Schizophrenia.
    Psychiatry Res. 2021;306:114255.
    >> Share

  375. DAMIANO RF, Avrichir BS, Melzer-Ribeiro DL, Sallet PC, et al
    Which are the best evidence-based therapeutic options for clozapine and ECT resistant schizophrenia? A case-report.
    Psychiatry Res. 2021;305:114248.
    >> Share

  376. PAWELCZYK A, Lojek E, Radek M, Pawelczyk T, et al
    Prosodic deficits and interpersonal difficulties in patients with schizophrenia.
    Psychiatry Res. 2021;306:114244.
    >> Share

  377. LUO X, Zhang L, Zhang J, Chen H, et al
    Changes in the cognitive function of Chinese college students with a clinical high risk of psychosis.
    Psychiatry Res. 2021;305:114242.
    >> Share

  378. CLAYSON PE, Molina JL, Joshi YB, Thomas ML, et al
    Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.
    Psychiatry Res. 2021;305:114239.
    >> Share

  379. JIANG W, Rootes-Murdy K, Chen J, Bizzozero NIP, et al
    Multivariate alterations in insula - Medial prefrontal cortex linked to genetics in 12q24 in schizophrenia.
    Psychiatry Res. 2021;306:114237.
    >> Share

  380. SANCHEZ MC, Escurriola MF, Sanmartin MIF, Solntseva I, et al
    Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care.
    Psychiatry Res. 2021;306:114233.
    >> Share

  381. BRYCE S, Zbukvic I, Wood SJ, Allott K, et al
    Cognitive remediation to address impairment in schizophrenia: Moving beyond effectiveness and toward implementation.
    Psychiatry Res. 2021;305:114232.
    >> Share

  382. MINICHINO A, Singh F, Pineda J, Friederich E, et al
    Corrigendum to 'Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD)' [Psychiatry Research 238 (2016) 374-377].
    Psychiatry Res. 2021;306:114177.
    >> Share

  383. SARZYNSKA-WAWER J, Wawer A, Pawlak A, Szymanowska J, et al
    Detecting formal thought disorder by deep contextualized word representations.
    Psychiatry Res. 2021;304:114135.
    >> Share

    September 2021
  384. LUDTKE T, Ruegg N, Moritz S, Berger T, et al
    Insight and the number of completed modules predict a reduction of positive symptoms in an Internet-based intervention for people with psychosis.
    Psychiatry Res. 2021;306:114223.
    >> Share

  385. ZOU DS, Cowan HR, Azis M, Mittal VA, et al
    Reciprocal Social Behavior and Related Social Outcomes in Individuals at Clinical High Risk for Psychosis.
    Psychiatry Res. 2021;306:114224.
    >> Share

  386. SRIVASTAVA A, Dada O, Qian J, Al-Chalabi N, et al
    Epigenetics of Schizophrenia.
    Psychiatry Res. 2021;305:114218.
    >> Share

  387. FERNANDO R, Gan L, Xiao J, Yun Y, et al
    Hyperprolactinemia induced by brexpiprazole in patients with schizophrenia: A case report.
    Psychiatry Res. 2021;305:114215.
    >> Share

  388. HOMMAN LE, Smart SE, O'Neill F, MacCabe JH, et al
    Attrition in longitudinal studies among patients with schizophrenia and other psychoses; findings from the STRATA collaboration.
    Psychiatry Res. 2021;305:114211.
    >> Share

  389. MISHRA A, Soni AB, Umate MS, Andrade C, et al
    An exploratory evaluation of predictors of duration of untreated psychosis in first-episode psychosis in lower income patients.
    Psychiatry Res. 2021;305:114203.
    >> Share

  390. ZHU L, Zhang W, Zhu Y, Mu X, et al
    Cerebellar theta burst stimulation for the treatment of negative symptoms of schizophrenia: A multicenter, double-blind, randomized controlled trial.
    Psychiatry Res. 2021;305:114204.
    >> Share

  391. SHOSHINA II, Hovis JK, Felisberti FM, Santos NA, et al
    Visual processing and BDNF levels in first-episode schizophrenia.
    Psychiatry Res. 2021;305:114200.
    >> Share

  392. RABINOWITZ J, Rabinowitz AA
    Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Psychiatry Res. 2021;303:114114.
    >> Share

  393. VALERIO KE, Jonas KG, Perlman G, Bromet EJ, et al
    A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.
    Psychiatry Res. 2021;303:114111.
    >> Share

    August 2021
  394. KARTALCI S, Erbay MF, Kahraman A, Candir F, et al
    Evaluation of CSF flow dynamics in patients with schizophrenia using phase-contrast cine MRI.
    Psychiatry Res. 2021;304:114172.
    >> Share

  395. REINFELD S, Caceda R, Gil R, Strom H, et al
    Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report.
    Psychiatry Res. 2021;304:114165.
    >> Share

  396. LYU J, Zhang J, Hennessy DA
    Characteristics and Risk Factors for Suicide in People with Schizophrenia in Comparison to Those without Schizophrenia.
    Psychiatry Res. 2021;304:114166.
    >> Share

  397. YANG H, Xiao W, Yang M, Wang Y, et al
    Decreased neuregulin1beta1 in first episode and drug-naive patients with schizophrenia: Negative correlation with cognitive impairment.
    Psychiatry Res. 2021;304:114164.
    >> Share

  398. SAHIN D, Hever F, Bossert M, Herwig K, et al
    Early and middle latency auditory event-related potentials do not explain differences in neuropsychological performance between schizophrenia spectrum patients and matched healthy controls.
    Psychiatry Res. 2021;304:114162.
    >> Share

  399. DAURE C, Fortias M, Icick R, Delage C, et al
    Oral long acting antipsychotic penfluridol as a harm reduction treatment in a patient suffering from untreated schizophrenia and multiple drug dependence: A case report.
    Psychiatry Res. 2021;304:114147.
    >> Share

  400. DEYO C, Langdon R
    Cognitive correlates of 'Formal Thought Disorder' in a non-clinical sample with elevated schizotypal traits.
    Psychiatry Res. 2021;302:113971.
    >> Share

  401. BURNESS C, Corbet C, Beyene K, Webby C, et al
    Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing.
    Psychiatry Res. 2021;302:113996.
    >> Share

    July 2021
  402. DA MOTTA C, Pato MT, Barreto Carvalho C, Castilho P, et al
    The neurocognitive and functional profile of schizophrenia in a genetically homogenous European sample.
    Psychiatry Res. 2021;304:114140.
    >> Share

  403. VOPPEL AE, de Boer JN, Brederoo SG, Schnack HG, et al
    Quantified language connectedness in schizophrenia-spectrum disorders.
    Psychiatry Res. 2021;304:114130.
    >> Share

  404. BOSNJAK KUHARIC D, Makaric P, Kekin I, Rossini Gajsak L, et al
    Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
    Psychiatry Res. 2021;304:114131.
    >> Share

  405. GRACIA DFK, Gomes EMP, Coelho TA, Carriello M, et al
    Ficolin activation as a potential biomarker of the severity of schizophrenia.
    Psychiatry Res. 2021;304:114122.
    >> Share

  406. KU BS, Pauselli L, Covington MA, Compton MT, et al
    Computational linguistic analysis applied to a semantic fluency task: A replication among first-episode psychosis patients with and without derailment and tangentiality.
    Psychiatry Res. 2021;304:114105.
    >> Share

  407. SNELLEKSZ M, Dean B
    Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder.
    Psychiatry Res. 2021;303:114096.
    >> Share

  408. VASKINN A, Engelstad KN, Torgalsboen AK, Rund BR, et al
    Childhood trauma, social cognition and schizophrenia: Specific association between physical neglect and cognitive theory of mind in homicide offenders.
    Psychiatry Res. 2021;303:114093.
    >> Share

  409. JAGADHEESAN K, Danivas V, Itrat Q, Shekaran L, et al
    A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown.
    Psychiatry Res. 2021;303:114081.
    >> Share

    June 2021
  410. CORBERA S, Wexler BE, Bell MD, Pearlson G, et al
    Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.
    Psychiatry Res. 2021;303:114087.
    >> Share

  411. LI S, DeLisi LE, McDonough SI
    Rare germline variants in individuals diagnosed with schizophrenia within multiplex families.
    Psychiatry Res. 2021;303:114038.
    >> Share

  412. CASADO-ORTEGA A, Vila-Badia R, Butjosa A, Del Cacho N, et al
    Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis.
    Psychiatry Res. 2021;302:114040.
    >> Share

  413. ANDREOU D, Jorgensen KN, Wortinger LA, Engen K, et al
    Cytomegalovirus infection and IQ in patients with severe mental illness and healthy individuals.
    Psychiatry Res. 2021;300:113929.
    >> Share

  414. BRAUN D, Schlossmann J, Haen E
    Asymmetric dimethylarginine in psychiatric disorders.
    Psychiatry Res. 2021;300:113901.
    >> Share

    May 2021
  415. KELLY DL, Claxton A, Bidollari I, Du Y, et al
    Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
    Psychiatry Res. 2021;302:114030.
    >> Share

  416. GUILLAUME F, Thomas E
    Recollection and familiarity in schizophrenia:An ERP investigation using face recognition exclusion tasks.
    Psychiatry Res. 2021;302:113973.
    >> Share

  417. SCHEFFLER F, Phahladira L, Luckhoff H, du Plessis S, et al
    Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
    Psychiatry Res. 2021;302:114022.
    >> Share

  418. MUNOZ-SAMONS D, Tor J, Rodriguez-Pascual M, Alvarez-Subiela X, et al
    Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis.
    Psychiatry Res. 2021;303:114017.
    >> Share

  419. HELLER C, Weiss T, Del Re EC, Swago S, et al
    Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.
    Psychiatry Res. 2021;301:113979.
    >> Share

  420. ABEL DB, Salyers MP, Wu W, Monette MA, et al
    Quality versus quantity: Determining real-world social functioning deficits in schizophrenia.
    Psychiatry Res. 2021;301:113980.
    >> Share

    April 2021
  421. ALBA L, Coll C, Saez S, Alonso L, et al
    New-onset psychosis: A case report of brief psychosis related to COVID-19 infection.
    Psychiatry Res. 2021;301:113975.
    >> Share

  422. UCOK A, Karakas B, Sahin OS
    Formal thought disorder in patients with first-episode schizophrenia: Results of a one-year follow-up study.
    Psychiatry Res. 2021;301:113972.
    >> Share


  423. Discrepancies between staff and gold standard ratings of schizophrenia symptom severity.
    Psychiatry Res. 2021;301:113963.
    >> Share

  424. DE PERI L, Deste G, Vita A
    Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed.
    Psychiatry Res. 2021;301:113962.
    >> Share

  425. MEDALIA A, Saperstein AM, Stefancic A, Meyler S, et al
    Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.
    Psychiatry Res. 2021;301:113956.
    >> Share

  426. XIE YJ, Xi YB, Cui LB, Guan MZ, et al
    Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia.
    Psychiatry Res. 2021;300:113937.
    >> Share

  427. PENNOU A, Lecomte T, Khazaal Y, Potvin S, et al
    Does theory of mind predict specific domains of social functioning in individuals following a first episode psychosis?
    Psychiatry Res. 2021;301:113933.
    >> Share

  428. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Sequencing of the coding regions of GNBIL on chromosome 22q11.2 as a risk gene of schizophrenia.
    Psychiatry Res. 2021;300:113943.
    >> Share

  429. SCHURHOFF F, Corfdir C, Pignon B, Lajnef M, et al
    No alteration of leukocyte telomere length in first episode psychosis.
    Psychiatry Res. 2021;301:113941.
    >> Share

  430. VAERNES TG, Rossberg JI, Melle I, Nelson B, et al
    Basic self-disturbance in subjects at clinical high risk for psychosis: Relationship with clinical and functional outcomes at one year follow-up.
    Psychiatry Res. 2021;300:113942.
    >> Share

  431. STRASSNIG MT, Miller ML, Moore R, Depp CA, et al
    Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.
    Psychiatry Res. 2021;300:113924.
    >> Share

  432. SIDDIQUI SV, Nizamie SH, Siddiqui MA, Jahan M, et al
    Evaluation of N-400 Evoked Response Potential in schizophrenia: An endophenotype or a disease marker?
    Psychiatry Res. 2021;300:113907.
    >> Share

    March 2021
  433. AU RWC, Sezto HNW, Lam VWM, Wan YT, et al
    Brief report: A randomized controlled trial of a compensatory cognitive training to improve prospective memory performance in people with schizophrenia or depression.
    Psychiatry Res. 2021;300:113914.
    >> Share

  434. LI M, Liu Y, Qiu Y, Zhang J, et al
    The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
    Psychiatry Res. 2021;300:113899.
    >> Share

  435. SIMON AE, Keller P, Cattapan K
    Commentary about social avoidance and its significance in adolescents and young adults.
    Psychiatry Res. 2021;297:113718.
    >> Share

  436. TOYODA K, Hata T, Yamauchi S, Kinoshita S, et al
    A descriptive study of 10-year clozapine use from the nationwide database in Japan.
    Psychiatry Res. 2021;297:113764.
    >> Share

  437. O'CONNOR C, Vaughan S
    Does selectively endorsing different approaches to treating mental illness affect lay beliefs about the cause and course of mental illness?
    Psychiatry Res. 2021;297:113726.
    >> Share

    February 2021
  438. SREERAJ VS, Holla B, Ithal D, Nadella RK, et al
    Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study.
    Psychiatry Res. 2021;296:113647.
    >> Share

  439. MORRIS E, Batallones R, Ryan J, Slomp C, et al
    Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Psychiatry Res. 2021;296:113663.
    >> Share

  440. CAMUS D, Dan Glauser ES, Gholamrezaee M, Gasser J, et al
    Factors associated with repetitive violent behavior of psychiatric inpatients.
    Psychiatry Res. 2021;296:113643.
    >> Share

  441. GURCAN G, Senol SH, Yagcioglu AEA, Ertugrul A, et al
    Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.
    Psychiatry Res. 2021;296:113665.
    >> Share

  442. KHARE C, Mueser KT, Bahaley M, Vax S, et al
    Employment in people with severe mental illnesses receiving public sector psychiatric services in India.
    Psychiatry Res. 2021;296:113673.
    >> Share

    January 2021
  443. KETHARANATHAN T, Pereira A, Reets U, Walker D, et al
    Brain changes in NF-kappaB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation.
    Psychiatry Res. 2021;295:113564.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016